Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

37.49
-1.8000-4.58%
Post-market: 37.490.00000.00%16:44 EDT
Volume:1.09M
Turnover:41.22M
Market Cap:3.54B
PE:-6.38
High:39.33
Open:38.34
Low:37.13
Close:39.29
Loading ...

Ultragenyx Pharmaceutical Q1 EPS $(1.57) Beats $(1.59) Estimate, Sales $139.29M Miss $143.83M Estimate

Benzinga
·
07 May

BRIEF-Ultragenyx Q1 EPS USD -1.57 Vs. IBES Estimate USD -1.61

Reuters
·
07 May

Ultragenyx Reports First Quarter 2025 Financial Results and Corporate Update

THOMSON REUTERS
·
07 May

Ultragenyx Pharmaceutical Inc - Reaffirms 2025 Financial Guidance

THOMSON REUTERS
·
07 May

Eric Crombez, EVP and Chief Medical Officer, Reports Disposal of Ultragenyx Pharmaceutical Common Shares

Reuters
·
06 May

Ultragenyx Pharmaceutical Inc expected to post a loss of $1.61 a share - Earnings Preview

Reuters
·
03 May

Ultragenyx to Host Conference Call for First Quarter 2025 Financial Results and Corporate Update

GlobeNewswire
·
01 May

Ultragenyx Pharmaceutical (RARE) Gets a Buy from Barclays

TIPRANKS
·
28 Apr

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
23 Apr

BofA Adjusts Price Target on Ultragenyx Pharmaceutical to $80 From $83, Keeps Buy Rating

MT Newswires Live
·
17 Apr

Ultragenyx Pharmaceutical (RARE): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential

Insider Monkey
·
14 Apr

US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says

MT Newswires Live
·
11 Apr

Ultragenyx (RARE) Soars 9.2%: Is Further Upside Left in the Stock?

Zacks
·
10 Apr

RBC Capital Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
05 Apr

Ultragenyx Pharmaceutical (RARE) Gets a Buy from Truist Financial

TIPRANKS
·
03 Apr

Why Ultragenyx Pharmaceutical (RARE) Is Among the Best Mid Cap Biotech Stocks to Buy

Insider Monkey
·
30 Mar

BUZZ-Ultragenyx Pharma up after JPMorgan PT raise

Reuters
·
27 Mar

Ultragenyx Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
27 Mar

Ultragenyx Pharmaceutical Inc : JP Morgan Raises Target Price to $117 From $104

THOMSON REUTERS
·
27 Mar

Top Analyst Reports for Shell, Uber & TotalEnergies

Zacks
·
20 Mar